Showing 4491-4500 of 5910 results for "".
- Johnson & Johnson Vision Introduces Next-Generation TearScience Activator Clear for Treatment of MGDhttps://modernod.com/news/johnson-johnson-vision-introduces-next-generation-tearscience-activator-clear-for-treatment-of-mgd/2480795/Johnson & Johnson Vision announced the availability of the next-generation TearScience Activator Clear. Building on the legacy of the TearScience LipiFlow Thermal Pulsation System—a fully automated treatment for meibomian gland dysfunction (MGD)—Johnson & Johnson Vis
- Haag-Streit Launches the Eyestar 900 Anterior Chamber Suitehttps://modernod.com/news/haag-streit-launches-the-eyestar-900-anterior-chamber-suite/2480794/Haag-Streit has announced the launch of the Eyestar 900 Anterior Chamber Suite (AC-Suite) to compliment the Cataract Suite. The AC-Suite is designed to meet the growing demand for improved outcomes in cataract and refractive surgery. The Eyestar 900 is based on swep
- Ziemer Receives FDA Clearance for the FEMTO Z8 NEOhttps://modernod.com/news/ziemer-receives-fda-clearance-for-the-femto-z8-neo/2480792/Ziemer Ophthalmic Systems has received FDA clearance for its latest femtosecond laser, the FEMTO Z8 NEO—the successor of Femtosecond Laser LDV Z8. The FEMTO Z8 NEO provides advanced hardware, as well as new and improved software applications. The newly designed platform offer
- Orasis Announces Positive Phase 3 Topline Results of Novel Eye Drop Candidate, CSF-1, for the Treatment of Presbyopiahttps://modernod.com/news/orasis-announces-positive-phase-3-topline-results-of-novel-eye-drop-candidate-csf-1-for-the-treatment-of-presbyopia/2480784/Orasis Pharmaceuticals announced that the phase 3 NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of CSF-1, its novel eye drop candidate, met their primary and key secondary endpoints. Additional details of these trials will be presented at future medical meet
- Ocuphire Appoints Jay Pepose, MD, PhD, as Chief Medical Advisor and Announces Upcoming Presentations at ASCRS 2022 and Eyeceleratorhttps://modernod.com/news/ocuphire-appoints-jay-pepose-md-phd-as-chief-medical-advisor-and-announces-upcoming-presentations-at-ascrs-2022-and-eyecelerator/2480777/Ocuphire Pharma announced the appointment of Jay Pepose, MD, PhD, as its Chief Medical Advisor. In addition, Dr. Pepose, Dr. Ralph Chu, and Dr. Marguerite McDonald will deliver three presentations on Nyxol at the American Society of Cataract and Refractive Surgery (ASCRS) which will
- Lumibird Medical Launches Nd:YAG Laser Capsulohttps://modernod.com/news/lumibird-medical-launches-new-ndyag-laser-capsulo/2480767/Lumibird Group, the parent company of Quantel Medical, announced the launch of the Capsulo Nd:YAG laser. Lumibird says the device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments. &ld
- ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategyhttps://modernod.com/news/proqr-announces-additional-sepofarsen-illuminate-trial-analyses-and-provides-update-on-company-strategy/2480765/ProQR Therapeutics provided an update on its sepofarsen program following a comprehensive post-hoc analysis of the data from the phase 2/3 Illuminate trial in people with CEP290-mediated Lebercongenital amaurosis 10, or LCA10, a
- Study: People with Vision Impairments up to Four Times More Likely to Suffer Mental Health Problemshttps://modernod.com/news/study-people-with-vision-impairments-up-to-four-times-more-likely-to-suffer-mental-health-problems/2480757/Research by international development organization Sightsavers, University of Ilorin, and the Kogi State Ministry of Health, in Nigeria has revealed links between vision impairment and poor mental health.
- Zeiss to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applicationshttps://modernod.com/news/zeiss-to-unveil-clinical-insights-supporting-the-value-of-new-data-driven-digital-workflow-solutions-and-software-applications/2480752/Zeiss Medical Technology will host ZEISS Innovation Day on April 7, 2022, showcasing clinical perspectives from global experts with first-hand experience integrating devices, data and software applications.
- Staar Surgical Announces First Implants of EVO Visian ICL in the UShttps://modernod.com/news/staar-surgical-announces-first-implants-of-evo-visian-icl-in-the-us/2480751/Staar Surgical announced the first implants of the EVO Visian Implantable Collamer lens (EVO ICL) in the US. The company also announced its program of meetings and presentations during the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington, DC, Apri